The Brachytherapy market can be segmented based on dosage type into low-dose rate (LDR) and high-dose rate (HDR) brachytherapy. LDR brachytherapy involves the continuous release of radiation over a longer period, while HDR brachytherapy delivers a high dose of radiation in a short amount of time. The preference for either dosage type may vary depending on the specific needs of the patient and the type of cancer being treated.
Product (Seeds, Electronic Brachytherapy):
Within the Brachytherapy market, the products can be divided into seeds and electronic brachytherapy devices. Seeds are small radioactive pellets that are implanted directly into the tumor, while electronic brachytherapy devices deliver radiation using electronic sources. The choice of product may depend on factors such as the size and location of the tumor, as well as the overall treatment plan designed by the healthcare provider.
Application (Prostate Cancer, Breast Cancer):
The Brachytherapy market can also be segmented based on application, with common indications including prostate cancer and breast cancer. Brachytherapy is often used in the treatment of prostate cancer due to its localized nature, while it can also be a valuable treatment option for certain types of breast cancer. The effectiveness of brachytherapy in these applications may vary depending on the stage of cancer and the overall health of the patient.